Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 25INDUSTRY 9NIH 2UNKNOWN 1OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Uterine Cervical Neoplasms 6Esophageal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Nasopharyngeal Carcinoma 5Lung Neoplasms 5Nasopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Neoplasms, Germ Cell and Embryonal 2Head and Neck Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Squamous Cell 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Recurrence 1Ovarian Neoplasms 1Oesophagogastric Cancer 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Cancer 1Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Endometrial Neoplasms 1EGFR Positive Non-small Cell Lung Cancer 1

Interventions

camrelizumab 2Injections 2toripalimab 1epigallocatechin gallate 1atezolizumab 1Zinc 1Tablets 1Quercetin 1Nivolumab 1Metformin 1Imatinib Mesylate 1Gemcitabine 1Everolimus 1Epirubicin 1Docetaxel 1Cisplatin 1Carboplatin 1Capecitabine 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Triple Negative Breast Neoplasms × Cisplatin × Clear all
NCT01939418 2017-10-03

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

National Cancer Center, Korea

Phase 1/2 Terminated
23 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡